Author:
Moriguchi Yoshio,Kan Norimichi,Okino Takashi,Teramura Yasufumi,Yamasaki Seiji,Ichinose You,Li Li,Sugie Tomoharu,Kuribayashi Kagemasa,Watanabe Yoshihiko,Imamura Masayuki
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. McCune CS, O'Donell RW, Marquis DM, Sahasrabudhe DM (1990) Renal cell carcinoma treated by vaccines for active specific immunotherapy: correlation of survival with skin testing by autologous tumor cells. Cancer Immunol Immunother 32:62–66
2. Schlag P, Manasterski M, Gerneth T, Hohenberger P, Dueck M, Herfarth C, Liebrich W, Schirrmacher V (1992) Active specific immunotherapy with Newcastle disease virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. Cancer Immunol Immunother 35:325–330
3. Vieweg J, Rosenthal FM, Bannerji R, Heston WDW, Fair WR, Gansbacher B, Gilboa E (1994) Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res 54:1760–1765
4. Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayama E, Taniyama T, Sakata T (1989) Exogenous expression of mouse interferon γ cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA 86:9456–9460
5. Maraskovsky E, Chen WF, Shortman K (1989) IL-2 and IFN-γ are two necessary lymphokines in development of cytotoxic T cells. J Immunol 143:1210–1214
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献